Microbiological surveillance in patients with cystic fibrosis

  • Paola Gualdi | paola.gualdi@apss.tn.it
  • Roberta Gazzini
  • Roberta Gazzini
  • Michele Schinella
  • Ermanno Baldo
  • Grazia Dinella
  • Cristina Guerzoni


Pulmonary infections in patients with cystic fibrosis (CF), are a major cause of morbidity and mortality. Prevention, diagnosis and therapy in cystic fibrosis, lead to the necessary collaboration between clinical and laboratory to identify effective strategies and appropriate solutions to address the problems inherent isolation micro-organisms, antibiotic strategies, overcoming of bacterial resistance and other problems management of these patients. The task of the microbiology laboratory and research in quickly and accurately, the agents responsible for these infectious processes, in order to isolate them from material, identify and determine their sensitivity antibiotics. A microbiological surveillance on 34 patients (13 males and 21 females) with CF and related to the “Support Services Provincial Trento for the treatment of cystic fibrosis “in the period July 2005 - August 2008, was carried out. 180 Gram positive and 278 of Gram negative bacteria as well as 235 fungi wre collected. Staphylococcus aureus was the most frequently organism found in patients with CF with an incidence of 23% on 156 strains isolated, Pseudomonas aeruginosa was collected 19% of all microorganisms isolated corresponding to 131 strains, Candida albicans is the yeast often isolated with a frequency 22% equal to 149 isolates, Aspergillus fumigatus was isolated at a rate of 8%. From the data we collected and processed has been noted that the local epidemiology of CF patients reflects as reported in the scientific literature and national international consulting, both as a type microorganisms that frequency also isolated compared to age groups. Considering the score of Bartlett as discriminating respiratory fitness of the material, it has been observed that only 32 samples over 327 total (10%) would materials insignificant. It follows therefore that the time of sample collection, followed by personnel (physiotherapists dedicated to CF patients), represents a crucial step in guarantee the quality of the preanalytical phase.



PlumX Metrics


Download data is not yet available.
Original Articles
cystic fibrosis, pulmonary infections, microbiological surveillance
  • Abstract views: 846

  • PDF: 784
How to Cite
Gualdi, P., Gazzini, R., Gazzini, R., Schinella, M., Baldo, E., Dinella, G., & Guerzoni, C. (2010). Microbiological surveillance in patients with cystic fibrosis. Microbiologia Medica, 25(2). https://doi.org/10.4081/mm.2010.2446

Most read articles by the same author(s)